Prestige Wealth Management Group LLC Grifols Sa Transaction History

Prestige Wealth Management Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 26, 2020	SELL	$15.4 - $20.16 $600 - $786	-39 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$18.24 - $21.45 $364 - $429	-20 Reduced 33.9%	39 $1,000
Q1 2020 May 15, 2020	BUY	$16.28 - $25.63 $765 - $1,204	47 Added 391.67%	59 $1,000
Q4 2019 Jan 28, 2020	BUY	$19.57 - $23.52 $234 - $282	12 New	12 $0
Q1 2019 Aug 16, 2019	SELL	$18.01 - $20.11 $702 - $784	-39 Closed	0 $0

Q4 2018 Apr 16, 2019	BUY	$17.44 - $21.53 $680 - $839	39 New	39 $1,000

150

140M

3.54M

919K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $4.78B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

Stay updated on Prestige Wealth Management Group LLC with notifications on news.